Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Vitamin d, Alendronic acid
Strength: 5600 UI + 70 mg
Dosage form: comprimido
Route: vía oral
Register: Spain (AEMPS)
Status: Marketed
Status in the register: Autorizado, comercializado
Authorised: 18 May 2021
Registration: 05310007IP1
Marketing authorisation holder: Merck Sharp & Dohme B.V.
Procedure: EU centralised
Supply: Medicamento Sujeto A Prescripción Médica

Vitamin d + Alendronic acid · 91,36 mg + 5600 UI · comprimido

Spain

ACIDO ALENDRONICO/COLECALCIFEROL TEVAGEN 70 mg/2.800 UI COMPRIMIDOSVitamin d + Alendronic acid · 81,20 mg + 0,07 mg · comprimidoSpain

Acido Alendronico/Colecalciferol Tevagen 70 MG/5.600 Ui ComprimidosVitamin d + Alendronic acid · 81,20 mg + 0,14 mg · comprimidoSpain

Adrovance 70 MG/2.800 Ui ComprimidosVitamin d + Alendronic acid · 2800 UI + 70 mg · comprimidoSpain

Adrovance 70 MG/5.600 Ui ComprimidosVitamin d + Alendronic acid · 5600 UI + 70 mg · comprimidoSpain

FOSAVANCE 70 mg/2.800 UI COMPRIMIDOSVitamin d + Alendronic acid · 70 mg + 70 µg · comprimidoSpain

Fosavance 70 MG/2.800 Ui ComprimidosVitamin d + Alendronic acid · 70 mg + 70 µg · comprimidoSpain